Given the critical role of GLUT1 in cancer cell metabolism, essential for metastasis, our findings suggest that the C/EBPβ-HIF-1α-GLUT1 axis serves as a potential target for lung cancer treatment. Here, SLC2A1 is linked to lung carcinoma.